查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1387274

全球 RNA 分析/转录组学市场：趋势、预测和竞争分析（~2030 年）

RNA Analysis/Transcriptomics Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

RNA 分析/转录组学的趋势和预测

预计2030年，全球RNA分析/转录组学市场规模将达到约123亿美元，2024年至2030年年复合成长率为10.5%。该市场的主要驱动力是个人化医疗需求的不断增长以及製药和生物技术行业的持续成长。全球RNA分析/转录组市场的未来前景广阔，在政府机构/学术中心、製药/生物技术、医院/诊所以及合约药物委外研发机构都有商机。

RNA 分析/转录组学市场洞察

根据 Lucintel 的预测，由于基于标靶序列的应用方法越来越受欢迎，药物研发预计将在预测期内实现最高成长。

由于人们越来越偏好基于结构的药物设计以及该地区大型製药企业和生物製药公司的存在，北美仍然是最大的地区。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球 RNA 分析/转录组学市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势与预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球RNA分析/转录组学市场趋势（2018-2023）与预测（2024-2030）
  • 全球 RNA 分析/转录组学市场：依产品类型
    • 消耗品
    • 装置
    • 软体
    • 服务
  • 全球 RNA 分析/转录组学市场：按技术分类
    • 实时萤光定量PCR (qPCR)
    • 微阵列
    • 顺序
    • 其他的
  • 全球 RNA 分析/转录组学市场：按应用分类
    • 药物研发
    • 诊断/疾病分析
    • 其他的
  • 全球 RNA 分析/转录组学市场：依最终用途分类
    • 政府机构/学术中心
    • 製药/生物技术
    • 医院/诊所
    • 药品委外研发机构
    • 其他的

第4章市场趋势与预测分析：按地区（2018-2030）

  • 全球 RNA 分析/转录组学市场：按地区
  • 北美RNA分析/转录组学市场
  • 欧洲RNA分析/转录组学市场
  • 亚太地区RNA分析/转录组市场
  • 其他地区RNA分析/转录组市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按产品类型分類的全球 RNA 分析/转录组学市场成长机会
    • 全球 RNA 分析/转录组学市场成长机会（按技术）
    • 全球 RNA 分析/转录组学市场成长机会（按应用）
    • 全球 RNA 分析/转录组学市场成长机会（依最终用途）
    • 全球 RNA 分析/转录组学市场成长机会（按地区）
  • 全球RNA分析/转录组学市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球RNA分析/转录组学市场的产能
    • 全球RNA分析/转录组学市场的合併、收购和合资企业
    • 认证和许可

第7章主要企业概况

  • Agilent Technologies
  • F. Hoffmann-La Roche
  • Illumina
  • QIAGEN
  • Thermo Fisher Scientific
  • Eurofins Scientific
  • Merck KGaA
  • Bio-Rad Laboratories
  • Pacific Bioscience of California
  • Affymetrix
简介目录

RNA Analysis/Transcriptomics Trends and Forecast

The future of the global RNA analysis/transcriptomics market looks promising with opportunities in the government institute & academic center, pharmaceutical & biotechnology, hospital & clinic, and contract research organizations markets. The global RNA analysis/transcriptomics market is expected to reach an estimated $12.3 billion by 2030 with a CAGR of 10.5% from 2024 to 2030. The major drivers for this market are increasing demand for personalized medicine and continual growth of pharmaceutical & biological industries.

A more than 150-page report is developed to help in your business decisions.

RNA Analysis/Transcriptomics by Segment

The study includes a forecast for the global RNA analysis/transcriptomics by product type, technology, application, end use, and region.

RNA Analysis/Transcriptomics Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Consumables
  • Instruments
  • Software
  • Services

RNA Analysis/Transcriptomics Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Real Time-PCR (qPCR)
  • Microarray
  • Sequencing
  • Others

RNA Analysis/Transcriptomics Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Drug Discovery
  • Diagnostics & Disease Profiling
  • Others

RNA Analysis/Transcriptomics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Government Institutes & Academic Centers
  • Pharmaceutical & Biotechnology
  • Hospitals & Clinics
  • Contract Research Organizations (CROs)
  • Others

RNA Analysis/Transcriptomics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of RNA Analysis/Transcriptomics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies RNA analysis/transcriptomics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the RNA analysis/transcriptomics companies profiled in this report include-

  • Agilent Technologies
  • F. Hoffmann-La Roche
  • Illumina
  • QIAGEN
  • Thermo Fisher Scientific
  • Eurofins Scientific
  • Merck KGaA
  • Bio-Rad Laboratories
  • Pacific Bioscience of California
  • Affymetrix

RNA Analysis/Transcriptomics Market Insights

Lucintel forecasts that drug discovery is expected to witness highest growth over the forecast period due to growing popularity of targeted sequencing-based approaches in this application.

North America will remain the largest region due to growing preference for structure-based drug designs and existence of major pharma and biopharma companies in the region.

Features of the Global RNA Analysis/Transcriptomics Market

Market Size Estimates: RNA analysis/transcriptomics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: RNA analysis/transcriptomics market size by various segments, such as by product type, technology, application, end use, and region in terms of value ($B).

Regional Analysis: RNA analysis/transcriptomics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, technologies, applications, end uses, and regions for the RNA analysis/transcriptomics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the RNA analysis/transcriptomics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the RNA analysis/transcriptomics market size?

Answer: The global RNA analysis/transcriptomics market is expected to reach an estimated $12.3 billion by 2030.

Q2. What is the growth forecast for RNA analysis/transcriptomics market?

Answer: The global RNA analysis/transcriptomics market is expected to grow with a CAGR of 10.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the RNA analysis/transcriptomics market?

Answer: The major drivers for this market are increasing demand for personalized medicine and continual growth of pharmaceutical & biological industries.

Q4. What are the major segments for RNA analysis/transcriptomics market?

Answer: The future of the RNA analysis/transcriptomics market looks promising with opportunities in the government institute & academic center, pharmaceutical & biotechnology, hospital & clinic, and contract research organizations markets.

Q5. Who are the key RNA analysis/transcriptomics market companies?

Answer: Some of the key RNA analysis/transcriptomics companies are as follows:

  • Agilent Technologies
  • F. Hoffmann-La Roche
  • Illumina
  • QIAGEN
  • Thermo Fisher Scientific
  • Eurofins Scientific
  • Merck KGaA
  • Bio-Rad Laboratories
  • Pacific Bioscience of California
  • Affymetrix

Q6. Which RNA analysis/transcriptomics market segment will be the largest in future?

Answer: Lucintel forecasts that drug discovery is expected to witness highest growth over the forecast period due to growing popularity of targeted sequencing-based approaches in this application.

Q7. In RNA analysis/transcriptomics market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to growing preference for structure-based drug designs and existence of major pharma and biopharma companies in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the RNA analysis/transcriptomics market by product type (consumables, instruments, software, and services), technology (real time-pcr (qPCR), microarray, sequencing, and others), application (drug discovery, diagnostics & disease profiling, and others), end use (government institutes & academic centers, pharmaceutical & biotechnology, hospitals & clinics, contract research organizations (CROs), and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global RNA Analysis/Transcriptomics Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global RNA Analysis/Transcriptomics Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global RNA Analysis/Transcriptomics Market by Product Type
    • 3.3.1: Consumables
    • 3.3.2: Instruments
    • 3.3.3: Software
    • 3.3.4: Services
  • 3.4: Global RNA Analysis/Transcriptomics Market by Technology
    • 3.4.1: Real Time-PCR (qPCR)
    • 3.4.2: Microarray
    • 3.4.3: Sequencing
    • 3.4.4: Others
  • 3.5: Global RNA Analysis/Transcriptomics Market by Application
    • 3.5.1: Drug Discovery
    • 3.5.2: Diagnostics & Disease Profiling
    • 3.5.3: Others
  • 3.6: Global RNA Analysis/Transcriptomics Market by End Use
    • 3.6.1: Government Institutes & Academic Centers
    • 3.6.2: Pharmaceutical & Biotechnology
    • 3.6.3: Hospitals & Clinics
    • 3.6.4: Contract Research Organizations (CROs)
    • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global RNA Analysis/Transcriptomics Market by Region
  • 4.2: North American RNA Analysis/Transcriptomics Market
    • 4.2.1: North American RNA Analysis/Transcriptomics Market by Application: Drug Discovery, Diagnostics & Disease Profiling, and Others
    • 4.2.2: North American RNA Analysis/Transcriptomics Market by End Use: Government Institutes & Academic Centers, Pharmaceutical & Biotechnology, Hospitals & Clinics, Contract Research Organizations (CROs), and Others
  • 4.3: European RNA Analysis/Transcriptomics Market
    • 4.3.1: European RNA Analysis/Transcriptomics Market by Application: Drug Discovery, Diagnostics & Disease Profiling, and Others
    • 4.3.2: European RNA Analysis/Transcriptomics Market by End Use: Government Institutes & Academic Centers, Pharmaceutical & Biotechnology, Hospitals & Clinics, Contract Research Organizations (CROs), and Others
  • 4.4: APAC RNA Analysis/Transcriptomics Market
    • 4.4.1: APAC RNA Analysis/Transcriptomics Market by Application: Drug Discovery, Diagnostics & Disease Profiling, and Others
    • 4.4.2: APAC RNA Analysis/Transcriptomics Market by End Use: Government Institutes & Academic Centers, Pharmaceutical & Biotechnology, Hospitals & Clinics, Contract Research Organizations (CROs), and Others
  • 4.5: ROW RNA Analysis/Transcriptomics Market
    • 4.5.1: ROW RNA Analysis/Transcriptomics Market by Application: Drug Discovery, Diagnostics & Disease Profiling, and Others
    • 4.5.2: ROW RNA Analysis/Transcriptomics Market by End Use: Government Institutes & Academic Centers, Pharmaceutical & Biotechnology, Hospitals & Clinics, Contract Research Organizations (CROs), and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global RNA Analysis/Transcriptomics Market by Product Type
    • 6.1.2: Growth Opportunities for the Global RNA Analysis/Transcriptomics Market by Technology
    • 6.1.3: Growth Opportunities for the Global RNA Analysis/Transcriptomics Market by Application
    • 6.1.4: Growth Opportunities for the Global RNA Analysis/Transcriptomics Market by End Use
    • 6.1.5: Growth Opportunities for the Global RNA Analysis/Transcriptomics Market by Region
  • 6.2: Emerging Trends in the Global RNA Analysis/Transcriptomics Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global RNA Analysis/Transcriptomics Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global RNA Analysis/Transcriptomics Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Agilent Technologies
  • 7.2: F. Hoffmann-La Roche
  • 7.3: Illumina
  • 7.4: QIAGEN
  • 7.5: Thermo Fisher Scientific
  • 7.6: Eurofins Scientific
  • 7.7: Merck KGaA
  • 7.8: Bio-Rad Laboratories
  • 7.9: Pacific Bioscience of California
  • 7.10: Affymetrix